
Sceolex Pharma Private Limited
About Sceolex Pharma Private Limited
Data last updated:
Sceolex Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24110KA2012PTC066676. Its GSTIN is 29AASCS3600F1Z8 (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Bellur Mekhala Dwarakanath and Sankara Guha Dwarakanath Bellur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 135/2 Bearing Bbmp Khatha No. 18 Guava Garden 5th Block Koramangala, Bengaluru, Karnataka, India – 560095.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr, a decline of 37% compared to the previous year. For the same year it recorded a net loss of ₹9.38 Lakh (net margin -8.4%) and EBITDA of -₹9.15 Lakh (EBITDA margin -8.2%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sceolex Pharma Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo. 135/2 Bearing Bbmp Khatha No. 18 Guava Garden 5th Block Koramangala, Bengaluru, Karnataka, India – 560095
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sceolex Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sceolex Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sceolex Pharma Private Limited, buy the company report.
Financials of Sceolex Pharma Private Limited
FY 2025 filings availableSceolex Pharma Private Limited reported revenue of ₹1.12 Cr (down 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 37% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.2% | ||||
| Net Profit Margin | -8.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sceolex Pharma Private Limited, buy the company report.
Board of directors of Sceolex Pharma Private Limited
Sceolex Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bellur Mekhala Dwarakanath | Director | 01 Nov 2013 | 13 Years 0 Months | Current |
| Sankara Guha Dwarakanath Bellur | Director | 01 Nov 2013 | 13 Years 0 Months | Current |
| Surayanarayanarao Savithri | Director | 01 Nov 2013 | 13 Years 0 Months | Current |
Auditor
Sceolex Pharma Private Limited is audited by NITYANANDA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NITYANANDA & CO | FY 2020 | 012595S |
Shareholding
The shareholding of Sceolex Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sceolex Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sceolex Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sceolex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sceolex Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AASCS3600F1Z8 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sceolex Pharma Private Limited, buy the company report.
Recent activity
Sceolex Pharma Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Raju Chowdappa Raghavendra ceased to be Director on 09 Jun 2015.
Frequently asked questions
Sceolex Pharma is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 November 2012 (14+ years old) and is registered under CIN U24110KA2012PTC066676.
Sceolex Pharma has 3 current directors:
- Bellur Mekhala Dwarakanath - Director
- Sankara Guha Dwarakanath Bellur - Director
- Surayanarayanarao Savithri - Director
The latest financial statements of Sceolex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sceolex Pharma is 29AASCS3600F1Z8, registered in Karnataka.
The CIN (Corporate Identification Number) of Sceolex Pharma is U24110KA2012PTC066676. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sceolex Pharma was incorporated on 13 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
Raju Chowdappa Raghavendra ceased to be Director on 09 Jun 2015. Arun Nagesh Avadhani ceased to be Additional Director on 10 May 2014. Bellur Mekhala Dwarakanath ceased to be Additional Director on 10 May 2014. Sceolex Pharma has 9 board changes on record in total.
The registered office of Sceolex Pharma is at No. 1352 Bearing Bbmp Khatha No. 18 Guava Garden 5th Block Koramangala, Bengaluru, Karnataka, India – 560095.
Sceolex Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sceolex Pharma is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.

